Progress in polymeric nano-medicines for theranostic cancer treatment

Imran Ali*, Mosa Alsehli, Luciana Scotti, Marcus Tullius Scotti, Shang Ting Tsai, Ruei Siang Yu, Ming Fa Hsieh, Jung Chih Chen

*Corresponding author for this work

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Cancer is a life-threatening disease killing millions of people globally. Among various medical treatments, nano-medicines are gaining importance continuously. Many nanocarriers have been developed for treatment, but polymerically-based ones are acquiring importance due to their targeting capabilities, biodegradability, biocompatibility, capacity for drug loading and long blood circulation time. The present article describes progress in polymeric nano-medicines for theranostic cancer treatment, which includes cancer diagnosis and treatment in a single dosage form. The article covers the applications of natural and synthetic polymers in cancer diagnosis and treatment. Efforts were also made to discuss the merits and demerits of such polymers; the status of approved nano-medicines; and future perspectives.
Original languageEnglish
Article number598
JournalPolymers
Volume12
Issue number3
DOIs
StatePublished - 6 Mar 2020

Keywords

  • Approved nano-medicines
  • Future perspectives
  • Merits and demerits
  • Polymeric nanoparticles
  • Theranostic cancer treatment

Fingerprint Dive into the research topics of 'Progress in polymeric nano-medicines for theranostic cancer treatment'. Together they form a unique fingerprint.

  • Cite this

    Ali, I., Alsehli, M., Scotti, L., Scotti, M. T., Tsai, S. T., Yu, R. S., Fa Hsieh, M., & Chen, J. C. (2020). Progress in polymeric nano-medicines for theranostic cancer treatment. Polymers, 12(3), [598]. https://doi.org/10.3390/polym12030598